AAAAAA

   
Results: 1-8 |
Results: 8
SQUAMOUS-CELL CARCINOMA OF THE LACRIMAL DRAINAGE SYSTEM - CASE-REPORTAND LITERATURE-REVIEW
Authors: DESTEFANI A LERDA W USAI A CAVALOT A RIELLA P BUSSI M
Citation: A. Destefani et al., SQUAMOUS-CELL CARCINOMA OF THE LACRIMAL DRAINAGE SYSTEM - CASE-REPORTAND LITERATURE-REVIEW, Tumori, 84(4), 1998, pp. 506-510
POLYCYSTIC-OVARY-SYNDROME - ANOMALIES IN PROGESTERONE PRODUCTION
Authors: DOLDI N GESSI A DESTEFANI A CALZI F FERRARI A
Citation: N. Doldi et al., POLYCYSTIC-OVARY-SYNDROME - ANOMALIES IN PROGESTERONE PRODUCTION, Human reproduction, 13(2), 1998, pp. 290-293
DETECTION OF MET ONCOGENE HEPATOCYTE GROWTH-FACTOR RECEPTOR IN LYMPH-NODE METASTASES FROM HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
Authors: GALEAZZI E OLIVERO M GERVASIO FC DESTEFANI A VALENTE G COMOGLIO PM DIRENZO MF CORTESINA G
Citation: E. Galeazzi et al., DETECTION OF MET ONCOGENE HEPATOCYTE GROWTH-FACTOR RECEPTOR IN LYMPH-NODE METASTASES FROM HEAD AND NECK SQUAMOUS-CELL CARCINOMAS, European archives of oto-rhino-laryngology, 254, 1997, pp. 138-143
PROGNOSTIC FACTORS OF CERVICAL LYMPH-NODE METASTASIS IN HEAD AND NECKSQUAMOUS-CELL CARCINOMA
Authors: MAGNANO M DESTEFANI A LERDA W USAI A RAGONA R BUSSI M CORTESINA G
Citation: M. Magnano et al., PROGNOSTIC FACTORS OF CERVICAL LYMPH-NODE METASTASIS IN HEAD AND NECKSQUAMOUS-CELL CARCINOMA, Tumori, 83(6), 1997, pp. 922-926
TREATMENT OF ORAL CAVITY AND OROPHARYNX SQUAMOUS-CELL CARCINOMA WITH PERILYMPHATIC INTERLEUKIN-2 - CLINICAL AND PATHOLOGICAL CORRELATIONS
Authors: DESTEFANI A VALENTE G FORNI G LERDA W RAGONA R CORTESINA G
Citation: A. Destefani et al., TREATMENT OF ORAL CAVITY AND OROPHARYNX SQUAMOUS-CELL CARCINOMA WITH PERILYMPHATIC INTERLEUKIN-2 - CLINICAL AND PATHOLOGICAL CORRELATIONS, Journal of immunotherapy with emphasis on tumor immunology, 19(2), 1996, pp. 125-133
PROGNOSTIC FACTORS FOR HEAD AND NECK TUMOR RECURRENCE
Authors: MAGNANO M BUSSI M DESTEFANI A MILAN F LERDA W FERRERO V GERVASIO F RAGONA R GABRIELE P CORTESINA G
Citation: M. Magnano et al., PROGNOSTIC FACTORS FOR HEAD AND NECK TUMOR RECURRENCE, Acta oto-laryngologica, 115(6), 1995, pp. 833-838
TEMPORARY REGRESSION OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEADAND NECK IS ACHIEVED WITH A LOW BUT NOT WITH A HIGH-DOSE OF RECOMBINANT INTERLEUKIN-2 INJECTED PERILYMPHATICALLY
Authors: CORTESINA G DESTEFANI A GALEAZZI E CAVALLO GP BADELLINO F MARGARINO G JEMMA C FORNI G
Citation: G. Cortesina et al., TEMPORARY REGRESSION OF RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEADAND NECK IS ACHIEVED WITH A LOW BUT NOT WITH A HIGH-DOSE OF RECOMBINANT INTERLEUKIN-2 INJECTED PERILYMPHATICALLY, British Journal of Cancer, 69(3), 1994, pp. 572-576
IMMUNOMODULATION THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: CORTESINA G DESTEFANI A SACCHI M ROSSO S GALEAZZI E
Citation: G. Cortesina et al., IMMUNOMODULATION THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Head & neck, 15(3), 1993, pp. 266-270
Risultati: 1-8 |